News | Mammography | May 10, 2016

U.K. study investigates whether mammogram readers become less accurate with more time on task

mammography, breast cancer detection, vigilance decrement, JAMA study, U.K.

May 10, 2016 — Longer time spent by film readers interpreting screening mammograms did not result in a reduced rate of breast cancer detection, according to a study appearing in the May 10 issue of JAMA.

Interpreting screening mammograms is a difficult and repetitive visual search task, for which characteristics of cancer are disguised among background breast parenchyma (tissue), resulting in false-positive recalls and missed cancers. In similar visual search tasks, a vigilance decrement (decreasing detection rates with time on task) has been observed in a large number of psychological laboratory experiments, including assembly line inspection tasks and airport baggage screening. In the United Kingdom (U.K.), two film readers independently evaluate each mammogram for signs of cancer.

Sian Taylor-Phillips, Ph.D., of the University of Warwick, Coventry, U.K., and colleagues investigated whether a vigilance decrement to detect cancer in breast screening practice exists and whether changing the order in which two experts examined a batch of mammograms could increase the cancer detection rate, through readers' experiencing peak vigilance at differing points within the reading batch.

The study was conducted at 46 specialized breast screening centers from the National Health Service (NHS) Breast Screening Program in England for one year. Three hundred sixty readers participated, all fully qualified to report mammograms in the NHS breast screening program. The two readers examined each batch of digital mammograms in the same order in the control group and in the opposite order to one another in the intervention group.

Among 1,194,147 women who had screening mammograms (596,642 in the intervention group; 597,505 in the control group), the images were interpreted in 37,688 batches (median batch size, 35), with each reader interpreting a median of 176 batches. After completion of all subsequent diagnostic tests, a total of 10,484 cases (0.88 percent) of breast cancer were detected. There was no significant difference in cancer detection rate with 5,272 cancers (0.88 percent) detected in the intervention group versus 5,212 cancers (0.87 percent) detected in the control group (recall rate, 4.14 percent versus 4.17 percent; rate of reader disagreements, 3.43 percent versus 3.48 percent).

“The intervention did not influence cancer detection rate, recall rate or rate of disagreement between readers. There was no pattern of decreasing cancer detection rate with time on task as predicted by previous research on vigilance decrements as a psychological phenomenon,” the authors wrote.

For more information: www.jama.jamanetwork.com


Related Content

News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
Subscribe Now